(CROX) Crocs - Overview
Sector: Consumer Cyclical | Industry: Footwear & Accessories | Exchange: NASDAQ (USA) | Market Cap: 5.293m USD | Total Return: 4.5% in 12m
Industry Rotation: +15.6
Avg Turnover: 93.6M USD
Peers RS (IBD): 75.0
EPS Trend: 20.7%
Qual. Beats: 16
Rev. Trend: 48.0%
Qual. Beats: 2
Warnings
Choppy
Tailwinds
No distinct edge detected
Crocs, Inc. (NASDAQ:CROX) designs, manufactures, and sells a broad portfolio of casual lifestyle footwear and accessories-including clogs, sandals, sneakers, and HEYDUDE-branded products-through wholesale partners, its own retail and outlet stores, e-commerce platforms, and third-party marketplaces worldwide. Founded in 1999 and headquartered in Broomfield, Colorado, the company serves men, women, and children across multiple channels.
In its most recent fiscal year, Crocs generated $2.52 billion in revenue, up 7% year-over-year, with an adjusted EPS of $1.20 and a gross margin of 45%, reflecting strong demand for its diversified product mix. E-commerce now accounts for roughly 40% of total sales, while the HEYDUDE brand contributed about 15% of FY2023 revenue, highlighting the successful expansion beyond its core clog offering. The broader footwear sector is benefiting from continued consumer preference for comfort-driven products and a resilient discretionary spend environment despite modest inflation pressures.
For a deeper dive, you might explore Crocs valuation on ValueRay.
- HEYDUDE brand growth boosts overall revenue
- Crocs brand popularity sustains direct-to-consumer sales
- Supply chain disruptions impact manufacturing costs
- International expansion drives market share gains
| Net Income: -81.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -3.39 > 1.0 |
| NWC/Revenue: 4.60% < 20% (prev 3.22%; Δ 1.38% < -1%) |
| CFO/TA 0.17 > 3% & CFO 710.4m > Net Income -81.2m |
| Net Debt (1.48b) to EBITDA (342.4m): 4.33 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.7m) vs 12m ago -10.84% < -2% |
| Gross Margin: 58.33% > 18% (prev 0.59%; Δ 5.77k% > 0.5%) |
| Asset Turnover: 89.92% > 50% (prev 85.24%; Δ 4.68% > 0%) |
| Interest Coverage Ratio: 1.47 > 6 (EBITDA TTM 342.4m / Interest Expense TTM 178.9m) |
| A: 0.04 (Total Current Assets 885.9m - Total Current Liabilities 700.1m) / Total Assets 4.17b |
| B: 0.83 (Retained Earnings 3.48b / Total Assets 4.17b) |
| C: 0.06 (EBIT TTM 263.2m / Avg Total Assets 4.49b) |
| D: 1.19 (Book Value of Equity 3.44b / Total Liabilities 2.88b) |
| Altman-Z'' Score: 4.66 = AA |
| DSRI: 1.19 (Receivables 333.1m/283.9m, Revenue 4.04b/4.10b) |
| GMI: 1.01 (GM 58.33% / 58.76%) |
| AQI: 0.92 (AQ_t 0.65 / AQ_t-1 0.70) |
| SGI: 0.99 (Revenue 4.04b / 4.10b) |
| TATA: -0.19 (NI -81.2m - CFO 710.4m) / TA 4.17b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
Over the past week, the price has changed by +12.08%, over one month by +20.32%, over three months by +14.55% and over the past year by +4.46%.
- StrongBuy: 7
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 105.8 | 6.1% |
P/S = 1.2473
P/B = 3.2495
P/EG = 1.3926
Revenue TTM = 4.04b USD
EBIT TTM = 263.2m USD
EBITDA TTM = 342.4m USD
Long Term Debt = 1.23b USD (from longTermDebt, last quarter)
Short Term Debt = 85.8m USD (from shortTermDebt, last quarter)
Debt = 1.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.48b USD (from netDebt column, last quarter)
Enterprise Value = 6.78b USD (5.29b + Debt 1.61b - CCE 130.4m)
Interest Coverage Ratio = 1.47 (Ebit TTM 263.2m / Interest Expense TTM 178.9m)
EV/FCF = 10.28x (Enterprise Value 6.78b / FCF TTM 659.2m)
FCF Yield = 9.73% (FCF TTM 659.2m / Enterprise Value 6.78b)
FCF Margin = 16.31% (FCF TTM 659.2m / Revenue TTM 4.04b)
Net Margin = -2.01% (Net Income TTM -81.2m / Revenue TTM 4.04b)
Gross Margin = 58.33% ((Revenue TTM 4.04b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 54.68% (prev 58.52%)
Tobins Q-Ratio = 1.62 (Enterprise Value 6.78b / Total Assets 4.17b)
Interest Expense / Debt = 1.32% (Interest Expense 21.3m / Debt 1.61b)
Taxrate = 17.33% (22.1m / 127.2m)
NOPAT = 217.5m (EBIT 263.2m * (1 - 17.33%))
Current Ratio = 1.27 (Total Current Assets 885.9m / Total Current Liabilities 700.1m)
Debt / Equity = 1.25 (Debt 1.61b / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = 4.33 (Net Debt 1.48b / EBITDA 342.4m)
Debt / FCF = 2.25 (Net Debt 1.48b / FCF TTM 659.2m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.81% (Net Income -81.2m / Total Assets 4.17b)
RoE = -5.37% (Net Income TTM -81.2m / Total Stockholder Equity 1.51b)
RoCE = 9.59% (EBIT 263.2m / Capital Employed (Equity 1.51b + L.T.Debt 1.23b))
RoIC = 7.59% (NOPAT 217.5m / Invested Capital 2.86b)
WACC = 8.39% (E(5.29b)/V(6.91b) * Re(10.62%) + D(1.61b)/V(6.91b) * Rd(1.32%) * (1-Tc(0.17)))
Discount Rate = 10.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.89%
[DCF] Terminal Value 78.78% ; FCFF base≈764.8m ; Y1≈864.1m ; Y5≈1.17b
[DCF] Fair Price = 347.9 (EV 18.96b - Net Debt 1.48b = Equity 17.48b / Shares 50.2m; r=8.39% [WACC]; 5y FCF grow 15.10% → 3.0% )
EPS Correlation: 20.69 | EPS CAGR: 3.00% | SUE: 2.64 | # QB: 16
Revenue Correlation: 47.99 | Revenue CAGR: 10.43% | SUE: 2.20 | # QB: 2
EPS next Quarter (2026-06-30): EPS=4.31 | Chg7d=+0.013 | Chg30d=-0.001 | Revisions Net=+5 | Analysts=13
EPS current Year (2026-12-31): EPS=13.35 | Chg7d=+0.059 | Chg30d=+0.044 | Revisions Net=+14 | Growth EPS=+6.7% | Growth Revenue=-0.0%
EPS next Year (2027-12-31): EPS=14.25 | Chg7d=+0.073 | Chg30d=+0.067 | Revisions Net=+7 | Growth EPS=+6.7% | Growth Revenue=+2.5%
[Analyst] Revisions Ratio: +0.56 (7 Up / 2 Down within 30d for Next Quarter)